Target intelligence / Profile preview

Bacterial 50S ribosomal subunit P-site (50S P-site)

Target
50S P-site
Molecular classification
Ribonucleoprotein, Ribosomal RNA, Peptidyl transferase center
01

Overview

The bacterial 50S ribosomal subunit P-site (peptidyl site) region near the 3' CCA end of tRNA is a critical functional domain within the peptidyl transferase center (PTC). This site is responsible for accommodating the acceptor stem of the peptidyl-tRNA, positioning the nascent peptide chain for the addition of the next amino acid during translation elongation (PNAS, 2013; NAR, 2021). Antibiotics targeting this region, such as pleuromutilins (e.g., lefamulin) and blasticidin S, exert their antimicrobial effects by physically obstructing the P-site or inducing conformational distortions in the tRNA's CCA terminus (NIH, 2016; PNAS, 2013). These interactions prevent the proper alignment of substrates required for peptide bond formation and can also interfere with translation termination by blocking release factor access (NAR, 2021; NIH, 2018). Because this site is highly conserved and essential for bacterial viability, it serves as a potent target for antimicrobial therapy, particularly against multidrug-resistant Gram-positive pathogens (NIH, 2019). However, therapeutic challenges include the potential for cross-reactivity with mitochondrial ribosomes and the emergence of resistance mechanisms such as Cfr-mediated rRNA methylation or specific mutations in ribosomal proteins (NIH, 2007; NIH, 2016).

Other names
P-site of the peptidyl transferase centerCCA-binding region of the P-site23S rRNA P-siteBacterial large ribosomal subunit P-sitePeptidyl-tRNA binding site
02

Mechanism of action

Antibiotics targeting this region bind to the peptidyl transferase center (PTC) of the 50S subunit, specifically interacting with the P-site. This binding either sterically blocks the accommodation of the 3' CCA end of the peptidyl-tRNA or induces a conformational distortion (e.g., bending the CCA end toward the A-site), which prevents peptide bond formation and inhibits translation termination by interfering with release factor binding (PNAS, 2013; NIH, 2016).

03

Biological functions

Protein synthesisPeptide bond formationTranslation elongationTranslation terminationPeptidyl-tRNA binding
04

Disease associations

Infection
05

Safety considerations

QT interval prolongationEmbryo-fetal toxicityMitochondrial protein synthesis inhibitionSelectivity issues with eukaryotic ribosomes
06

Interacting drugs

Lefamulin

8 more in the full profile.

07

Biomarkers

Cfr methyltransferase23S rRNA mutations (e.g., A2503, U2506, U2585)Ribosomal protein L3 mutations

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit P-site (50S P-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit P-site (50S P-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call